Azevedo, R. S., Jabbour, E., Jain, N., Haddad, F., Kebriaei, P., Khouri, I., Shpall, E., Champlin, R., Senapati, J., Kugler, E., Karrar, O., Maroun, E., Garris, R., Ravandi, F., Kantarjian, H., Short, N. (2025). Predictors of survival with and without allogeneic stem cell transplantation after first salvage therapy with blinatumomab and/or inotuzumab ozogamicin for Relapsed/Refractory B-cell acute lymphoblastic leukemia. Blood. https://doi.org/10.1182/blood-2025-549